COMMONWEALTH EQUITY SERVICES, LLC

Position in ROIV — Roivant Sciences Ltd.

CIK 312272 WALTHAM, MA

Position in ROIV

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$358,040

-$109,923 QoQ

Shares Held

10,117

-40.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#314

of 494 holders

Holding Since

Dec 2023

11 quarters on record

Healthcare · as of Jun 30, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $124,479,036 across 113 Biotechnology names. ROIV ranks #51 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	50,813	$25,240,341
2	TGTX	Tg Therapeutics, Inc.	186,987	$10,273,065
3	REGN	Regeneron Pharmaceuticals, Inc.	14,671	$9,147,955
4	EXEL	Exelixis, Inc.	105,998	$5,767,351
5	TARS	Tarsus Pharmaceuticals, Inc.	79,888	$5,028,150
6	MRNA	Moderna, Inc.	66,546	$4,660,216
7	KRYS	Krystal Biotech, Inc.	12,116	$4,503,153
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,170	$4,496,906

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$358,040	10,117	-40.1%	Shares	Sole	2026-07-29
2026-03-31	$467,963	16,894	-34.4%	Shares	Sole	2026-04-27
2025-12-31	$558,861	25,754	-12.9%	Shares	Sole	2026-02-12
2025-09-30	$447,454	29,574	-12.2%	Shares	Sole	2025-10-22
2025-06-30	$379,641	33,686	-4.2%	Shares	Sole	2025-08-06
2025-03-31	$354,925	35,176	+79.6%	Shares	Sole	2025-05-09
2024-12-31	$231,726	19,588	+24.2%	Shares	Sole	2025-02-10
2024-09-30	$182,043	15,775	+7.3%	Shares	Sole	2024-10-18
2024-06-30	$155,421	14,704	-22.3%	Shares	Sole	2024-07-31
2024-03-31	$199,501	18,928	+9.2%	Shares	Sole	2024-04-29
2023-12-31	$194,604	17,329	—	Shares	Sole	2024-02-06
No filing history on record for this holder in this stock.